The AUC values were 0.838 (1-year ROC), 0.864 (3-year ROC), and 0.833 (5-year ROC), which showed that the expression of PYGL could reliably predict the 1-, 3- and 5-year survival rate of patients with gliomas (Figure 4). This evidence concerns the gene PYGL and central nervous system cancer.